December 13, 2023
Mad Hedge Technology Letter December 13, 2023 Fiat Lux Featured Trade: (RIVIAN SPEEDS UP) (RIVN), (TSLA)
This author has not written his bio yet.
But we are proud to say that april@madhedgefundtrader.com contributed 2883 entries already.
Mad Hedge Technology Letter December 13, 2023 Fiat Lux Featured Trade: (RIVIAN SPEEDS UP) (RIVN), (TSLA)
One company I am quite bullish on is EV maker Rivian (RIVN). They make great cars, but they also lose money by the fistful. How bad is it? Rivian lost $1.19 a share in Q3, less than feared, while revenue jumped 149% $1.34 billion. The EV startup produced 16,304 vehicles and delivered 15,564 vehicles in
(THIS SELF-DRIVING CAR TECHNOLOGY STOCK WILL REAP REWARDS FOR ITS INVESTORS) December 13, 2023 Hello everyone, Ever heard of Innoviz Technologies (INVZ)? It’s an Israeli firm, which is listed on the Nasdaq, and it makes sensors and automotive software that are key to enabling driverless cars. The company’s LiDAR (“light detection and ranging”)
Global Market Comments December 13, 2023 Fiat Lux Featured Trade: (JACQUIE MUNRO JANUARY 9, 2024 BRISBANE AUSTRALIA STRATEGY LUNCHEON) (THE MAD HEDGE DECEMBER 5-7 TRADERS & INVESTORS SUMMIT VIDEOS ARE UP!)
The Mad Hedge Summit videos from the December 5-7 confab are now available. Listen to 24 speakers opine on the best strategies, tactics, and instruments to use in these volatile markets. It is a true smorgasbord of investment strategies. Find the best one to suit your own goals. The product discounts offered last week are
Mad Hedge Biotech and Healthcare Letter December 12, 2023 Fiat Lux Featured Trade: (A REBOUNDING BLUE CHIP) (PFE), (LLY), (NVO), (RHHBY), (AZN), (SGEN), (VKTX), (TERN), (GPCR), (ALT)
In the maelstrom of 2023, Pfizer (PFE) found itself navigating through a tempest, much to the dismay of shareholders. The aftermath? A harrowing -40% total return loss, leaving shareholders reeling. This downturn followed Pfizer's COVID-19 vaccine triumph, a success story that lost its sheen as global government demand for the vaccine and Paxlovid antiviral dwindled.
Global Market Comments December 12, 2023 Fiat Lux Featured Trade: (CONTANGO IN THE VIX EXPLAINED ONE MORE TIME), (UVXY), (VIX), (SPY) (QUANTITATIVE EASING EXPLAINED TO A 12-YEAR-OLD), (TESTIMONIAL)
Mad Hedge Technology Letter December 11, 2023 Fiat Lux Featured Trade: (DIGITAL MARKETING REBOUND) (PINS), (SNAP)
In prior years, big social media companies were the class of the tech industry. It’s not so much like that today but they still have highly profitable models and a lot of juice left in the tank. I do believe big social media companies will still do well in 2024 because they have proved themselves
Legal Disclaimer
There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.
